The Blue Box Biomedical Solutions

Breast cancer is the most treatable cancer, yet it remains the leading cause of death by cancer in women—largely because national screening programs miss up to 1 in 3 cases. The problem is even worse for women with dense breasts, who make up 50% of the screening population and for whom mammography is less reliable. At The Blue Box, we've developed a urine-based breast cancer test with a high sensitivity, outperforming mammography, especially in women with dense breasts.